Skip To Main Content
Shehla Shakoor on Muck Rack

Shehla Shakoor

Lawrence
As seen in: Endpoints News
Managing Director @endpts working on editorial events & marketing right now. previously: sales, operations, editorial.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Shehla

Contact Shehla, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

R.W. Baird Health Care Conference

|
By Shehla Shakoor
| Endpoints News Verified
R.W. Baird Health Care Conference The best place to read Endpoints News? In your inbox. Comprehensive daily news report for those who discover, develop, and market drugs. Join 33,900+ biopharma pros who read Endpoints News by email every day. Free Subscription Read next LATEST FEATURED Subscribe to Endpoints News Thank you for staying with us. It's great to have you on board! Aww, shucks. Perhaps you can tell us what we could do to make you interested in subscribing?
Open in Who Shared Issue with article?

Roche puts down $75M to sign on as new partner for Ionis’ dry AMD drug, following Huntington’s deal

|
By Shehla Shakoor
| Endpoints News Verified
Ionis is teaming up with Roche again, this time to develop an antisense drug for dry AMD with an upfront payment of $75 million to the biotech and up to $684 million more possible on the backend. Initially optioned to GSK, IONIS-FB-LRx was dumped alongside inotersen during GSK’s rare disease pipeline upheaval last summer.
Open in Who Shared Issue with article?

LogicBio guns for $75M IPO; Alexandria lands a new biotech building on Long Island

|
By John Carroll Verified, Arsalan Arif, Shehla Shakoor
| Endpoints News Verified
October 10, 2018 12:15 PM EDT Shehla Shakoor Log­icBio guns for $75M IPO; Alexan­dria lands a new biotech build­ing on Long Is­land → Pro­lif­ic life-sci­ence de­vel­op­er Alexan­dria Re­al Es­tate Eq­ui­ties just plopped down $75M for a build­ing in Long Is­land City fresh off the heels of its pur­chase of Pfiz­er HQ in Man­hat­tan ear­li­er this year. → Cam­bridge-based Log­icBio is aim­ing for a $75 mil­lion haul dur­ing its IPO run.
Open in Who Shared Issue with article?
See all 261 articles